TGFB1 and cancer: We postulated that some of the cell surface molecules on TGF-β1-treated cancer cells closely resemble the surface molecules on OBs because TGF-β1 treatment enriches the population of osteogenic progenitors and activates the early differentiation of OBs by inhibiting late differentiation of OBs [9, 10].